Allelica at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

Allelica at ASHG 2026 in Montréal: Booth 1427.

Organization	ASHG 2026 Attendance
A Allelica New York, New York
Allelica sells multi-ancestry polygenic risk tests, genomic risk software, and clinical reporting solutions to physicians, laboratories, health systems, and pharma. VA and Allelica launch cardiovascular genomics prevention study (2026-03) › VA and Allelica launch cardiovascular genomics prevention study · 2026-03-17 “The U.S. Department of Veterans Affairs (VA) has partnered with the leaders in precision medicine at Allelica to perform a clinical genomics study.” PRS recognized in 2026 ACC/AHA cardiovascular guidelines · 2026-03-16 “Polygenic risk scores (PRS) have been recognized as a risk-enhancing factor in the 2026 American College of Cardiology (ACC) and American Heart Association (AHA) Guidelines.” Allelica licenses Cambridge BOADICEA model for breast cancer risk assessment · 2026-01-22 “Through this license, Allelica is authorized to deploy the BOADICEA v7 model within its commercial offerings for use by healthcare professionals in clinical care.” Source: company newsroom Raised $1.75M (Seed) › $1.75 million seed financing “Allelica Raises $1.75 Million in Seed Financing to Advance Polygenic Risk Score (PRS) Analysis into Clinical Practice” Source: funding announcement	Booth Exhibiting at Booth 1427 Wed, Oct 219:30am–4:30pmThu, Oct 229:30am–6:15pmFri, Oct 239:30am–4:30pm

Organization

ASHG 2026 Attendance

Allelica

New York, New York

Allelica sells multi-ancestry polygenic risk tests, genomic risk software, and clinical reporting solutions to physicians, laboratories, health systems, and pharma.

VA and Allelica launch cardiovascular genomics prevention study (2026-03)

›

VA and Allelica launch cardiovascular genomics prevention study · 2026-03-17

“The U.S. Department of Veterans Affairs (VA) has partnered with the leaders in precision medicine at Allelica to perform a clinical genomics study.”

PRS recognized in 2026 ACC/AHA cardiovascular guidelines · 2026-03-16

“Polygenic risk scores (PRS) have been recognized as a risk-enhancing factor in the 2026 American College of Cardiology (ACC) and American Heart Association (AHA) Guidelines.”

Allelica licenses Cambridge BOADICEA model for breast cancer risk assessment · 2026-01-22

“Through this license, Allelica is authorized to deploy the BOADICEA v7 model within its commercial offerings for use by healthcare professionals in clinical care.”

Source: company newsroom

Raised $1.75M (Seed)

›

$1.75 million seed financing

“Allelica Raises $1.75 Million in Seed Financing to Advance Polygenic Risk Score (PRS) Analysis into Clinical Practice”

Source: funding announcement

Booth

Exhibiting at Booth 1427

Wed, Oct 219:30am–4:30pmThu, Oct 229:30am–6:15pmFri, Oct 239:30am–4:30pm